Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15

Gynecologic Oncology

Volumn 61, Issue 2, 1996, Pages 221-226

  John, Madhu ^a,b,c   Flam, Marshall ^a,b   Caplan, Richard ^d   Rotman, Marvin ^e   Quwey, Jeanne ^b   Steinfeld, Alan ^f   Russell, Anthony ^g,h  

^a California Cancer Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Cancer Center at St Agnes   (United States)

^d RADIATION THERAPY ONCOLOGY GROUP   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g Radiation Oncology Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION INJURY; SKIN TOXICITY; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0029912310     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0129     Document Type: Article

References (29)

1. Cramer, D. W. The role of cervical cytology in the declining morbidity and mortality of cervical cancer, Cancer 34, 2018-2027 (1974).
2. Brady, L. W., Rotman, M., and Calvo, F. A. New advances in radiation oncology for gynecologic cancer, Cancer (Suppl.) 71, 1652-1659 (1993).
3. John, M., and Flam, M. Gynecologic system, in Chemoradiation: An integrated approach to cancer treatment (M. John, M. Flam, S. S. Legha and T. L. Phillips, Eds.), Lea & Febiger, Philadelphia, pp. 374-383 (1993).
4. John, M., Cooke, J. K., Flam, M., Padmanabhan, A., and Ager-Mowry, P. Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma, Gynecol. Oncol. 28, 101-110 (1987).
5. John, M., Flam, M., Sikic, B., Rotman, M., Cooper, J., Malec, M., Hannigan, J., and Phillips, T. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma, A phase I-II prospective intergroup NCOG-RTOG study, Gynecol. Oncol. 37, 1-5 (1990).
6. Rotman, M., John, M., and Boyce, J. Prognostic factors in cervical carcinoma: Implications in staging and management, Cancer 48, 560-567 (1981).
7. Perez, C. A., Camel, H. M., Askin, F., and Breaux, S. Endometrial extension of carcinoma of the uterine cervix: A prognostic factor that may modify staging, Cancer 48, 170-180 (1981).
8. Piver, M. S., and Chung, W. S. Prognostic significance of cervical lesion size and pelvic nodal metasteses in cervical carcinoma, Obstet. Gynecol. 46, 507-510 (1975).
9. John, M. Grading of chemoradiation toxicity, in Chemoradiation: An integrated approach to cancer treatment (M. John, M. Flam, S. S. Legha, and T. L. Phillips, Eds.), Lea & Febiger, Philadelphia, pp. 601-606 (1993).
10. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
11. Caplan, R. J., Pajak, T. F., and Cox, J. D. Analysis of the probability and risk of cause-specific failure, J. Radiat. Oncol. Biol. Phys. 29, 1183-1186 (1994).
12. Hanks, G. E., Herring, D. F., and Kramer, S. Patterns of care outcome studies: Results of the national practice survey in cancer of the cervix, Cancer 51, 959-967 (1983).
13. Lanciano, R. M., Pajak, T. F., Martz, K., and Hanks, G. E. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study, Int. J. Radiat. Oncol. Biol. Phys. 25, 391-397 (1993).
14. Kottmeier, H. L., Kolstad, P., McGarrity, K. A., Peterson, F., and Ulfelder, H. (Eds.) Annual report on the results of treatment in gynecological cancer, Vol. 18, Stockholm, International Federation of Obstetrics and Gynecology (1982).
15. Watson, E. R., Halnan, K. E., Dische, S., Saunders, M. I., Cade, I. S., McEwen, J. B., Wiernik, G., Perrins, D. J., and Sutherland, I. Hyperbaric oxygen and radiotherapy: A Medical Research Council trial in carcinoma of the cervix, Br. J. Radiol. 51, 879-887 (1978).
16. Maor, M. H., Gillespie, B. W., Peters, L. J., Wambersie, A., Griffin, T. W., Thomas, F. J., Cohen, L., Conner, N., and Gardner, P. Neutron therapy in cervical cancer: Results of a phase III RTOG study, Int. J. Radiat. Oncol. Biol. Phys. 14, 885-891 (1988).
17. Leibel, S., Bauer, M., Wasserman, T., Marcial, V., Rotman, M., Hornback, N., Cooper, J., Gillespie, B., Pakuris, E., Conner, N., and Martin-Durbin, L. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of an RTOG endorsed trial, Int. J. Radiat. Oncol. Biol. Phys. 13, 541-569 (1987).
18. Marcial, V. A., Amato, D. A., Marks, R. D., Rotman, M., Canoy, N., Figueroa-Valles, N., and Hanley, J. A. Split course versus continuous pelvis irradiation in carcinoma of the uterine cervix: A prospective randomized trial of the Radiation Therapy Oncology Group, Int. J. Radiat. Oncol. Biol. Phys. 9, 431-436 (1983).
19. Komaki, R., Pajak, T. F., Marcial, V. A., Rotman, M., Grigsby, P. W., Leibel, S. A., and Eifel, P. J., Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix, Phase I/II study of the Radiation Oncology Group, 88-05, Cancer 73, 2619-2625 (1994).
20. Potish, R. A., Farniok, K. E., and Twiggs, L. B., The interplay of local and distant control in the cure of cervical cancer, Cancer 66, 2514-2521 (1990).
21. Steel, G. Principles for the combination of radiotherapy and chemother-apy, in Combined radiotherapy and chemotherapy in clinical oncology (A. Horwich, Ed.), Arnold, London, pp. 14-22 (1992).
22. Goldie, J. H. Neoadjuvant combined modality therapy, in Chemoradiation: An integrated approach to cancer treatment (M. John, M. Flam, S. Legha, and T. Phillips, Eds) Lea & Febiger, Philadelphia, pp. 18-26 (1993).
23. Rotman, M., Choi, K., Guse, C., Marcial, V., Hornback, N., and John, M. Prophylactic irradiation of the para-aortic lymph-chain in Stage IIB and bulky Stage IB carcinoma of the cervix: Initial treatment results of RTOG 7920, Int. J. Radiat. Oncol. Biol. Phys. 19, 513-521 (1990).
24. Lanciano, R. M., Won, M., Coia, L. R., and Hanks, G. E. Pre-treatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 Patterns of Care Studies, Int. J. Radiat. Oncol. Biol. Phys. 20, 667 (1991).
25. Lowrey, G. C., Mendenhall, W. M., and Million, R. R. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis, Int. J. Radiat. Oncol. Biol. Phys. 24, 205-210 (1992).
26. Smiley, L. M., Burke, T. W., Silver, E. G., et al. Prognostic factors in stage IB squamous cervical cancer patients with low risk of recurrence, Obstet. Gynecol. 77, 271-275, (1991).
27. Grimard, L., Genest, P., Girard, A., et al. Prognostic significance of endometrial extension in carcinoma of the cervix, Gynecol. Oncol. 31, 301 (1988).
28. Buxton, E. J., Blackledge, G., Moued, J. J., Monaghan, J., Paterson, M., Tobias, J., Alcock, C., Spooner, D., and Meanwell, C. A. The role of ifosfamide in cervical cancer, Semin. Oncol. (Suppl.) 3(16), 60-67 (1989).
29. Angioli, R., Sevin, B. U., Perras, J. P., Untch, M., Hightower, R. D., Nguyen, H. N., Steren, A., Villani, C., and Averette, H. E. Rationale of combining radiation and interferon for the treatment of cervical cancer, Oncology 49, 445-449 (1992).